BRUKER CORPORATION (BRKR) Current Ratio
- Current ratio · latest quarter: Value 1.85×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.85× | Current assets / current liabilities. $2.23B ÷ $1.20B ≈ 1.85× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 2.23B USD | Assets, Current |
| Current obligations | 1.20B USD | Liabilities, Current |
| Cash and equivalents | 184.90M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Available-for-sale Securities, Current |
| Customer receivables | 545.90M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 1.12B USD | Inventory, Net |
| Payables | 200.20M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.23B | $1.20B | $184.90M | (m) | $545.90M | $1.12B | $200.20M | (m) | 1.85× |
| 2026-03-31 | $2.10B | $1.36B | $133.40M | (m) | $542.70M | $1.12B | $269.10M | (m) | 1.55× |
| 2025-12-31 | $2.21B | $1.28B | $298.80M | (m) | $544.90M | $1.09B | $215.90M | (m) | 1.73× |
| 2025-09-30 | $2.35B | $1.27B | $293.10M | (m) | $550.90M | $1.20B | $184.40M | (m) | 1.85× |
| 2025-06-30 | $2.16B | $1.35B | $92.00M | (m) | $522.60M | $1.22B | $243.00M | (m) | 1.61× |
| 2025-03-31 | $2.11B | $1.34B | $184.20M | (m) | $537.80M | $1.12B | $244.60M | (m) | 1.57× |
| 2024-12-31 | $2.05B | $1.28B | $183.40M | (m) | $565.50M | $1.07B | $234.10M | (m) | 1.60× |
| 2024-09-30 | $2.19B | $1.32B | $148.10M | (m) | $538.40M | $1.22B | $227.50M | (m) | 1.66× |
| 2024-06-30 | $2.15B | $1.30B | $169.70M | (m) | $507.20M | $1.18B | $220.30M | (m) | 1.65× |
| 2024-03-31 | $2.14B | $1.18B | $340.10M | (m) | $475.40M | $1.06B | $199.10M | (m) | 1.81× |
| 2023-12-31 | $2.16B | $1.20B | $488.30M | (m) | $492.00M | $968.30M | $202.70M | (m) | 1.80× |
| 2023-09-30 | $2.03B | $1.07B | $363.60M | (m) | $485.40M | $916.00M | $181.50M | (m) | 1.89× |
| 2023-06-30 | $2.18B | $1.05B | $574.80M | (m) | $450.80M | $914.60M | $188.80M | (m) | 2.08× |
| 2023-03-31 | $2.13B | $1.05B | $597.90M | (m) | $471.70M | $858.80M | $196.20M | (m) | 2.03× |
| 2022-12-31 | $2.11B | $914.30M | $645.50M | (m) | $472.70M | $800.10M | $178.40M | (m) | 2.31× |
| 2022-09-30 | $2.04B | $864.60M | $626.20M | (m) | $421.30M | $749.50M | $157.70M | (m) | 2.36× |
| 2022-06-30 | $2.09B | $818.40M | $723.00M | (m) | $402.60M | $759.00M | $154.90M | (m) | 2.55× |
| 2022-03-31 | $2.25B | $880.50M | $816.10M | (m) | $413.80M | $739.90M | $161.20M | (m) | 2.56× |
| 2021-12-31 | $2.47B | $938.50M | $1.07B | (m) | $416.90M | $710.10M | $147.40M | (m) | 2.63× |
| 2021-09-30 | $1.99B | $921.20M | $573.00M | (m) | $372.10M | $732.80M | $141.10M | (m) | 2.16× |
| 2021-06-30 | $1.97B | $954.60M | $608.10M | (m) | $337.00M | $730.20M | $142.60M | (m) | 2.06× |
| 2021-03-31 | $1.95B | $943.50M | $696.80M | (m) | $326.00M | $700.70M | $152.30M | (m) | 2.06× |
| 2020-12-31 | $1.93B | $791.90M | $681.80M | (m) | $335.30M | $692.30M | $134.60M | (m) | 2.43× |
| 2020-09-30 | $1.83B | $683.20M | $567.10M | (m) | $329.90M | $695.90M | $113.90M | (m) | 2.67× |
| 2020-06-30 | $1.96B | $749.70M | $746.80M | (m) | $324.50M | $665.40M | $119.20M | (m) | 2.61× |
| 2020-03-31 | $1.99B | $765.80M | $795.50M | (m) | $325.50M | $625.50M | $127.00M | (m) | 2.60× |
| 2019-12-31 | $1.80B | $645.60M | $678.30M | (m) | $362.20M | $577.20M | $118.40M | (m) | 2.78× |
| 2019-09-30 | $1.43B | $643.00M | $296.30M | (m) | $358.80M | $586.70M | $116.60M | (m) | 2.23× |
| 2019-06-30 | $1.41B | $641.00M | $282.50M | (m) | $348.00M | $594.60M | $123.70M | (m) | 2.19× |
| 2019-03-31 | $1.34B | $632.70M | $298.80M | (m) | $360.40M | $541.80M | $126.50M | (m) | 2.12× |
| 2018-12-31 | $1.30B | $599.30M | $322.40M | (m) | $357.20M | $509.60M | $104.50M | (m) | 2.18× |
| 2018-09-30 | $1.26B | $563.10M | $270.10M | (m) | $323.40M | $518.60M | $100.00M | (m) | 2.24× |
| 2018-06-30 | $1.18B | $531.50M | $258.70M | (m) | $278.80M | $509.40M | $104.60M | (m) | 2.22× |
| 2018-03-31 | $1.24B | $558.70M | $283.90M | (m) | $313.60M | $518.00M | $104.70M | (m) | 2.22× |
| 2017-12-31 | $1.36B | $524.50M | $325.00M | (m) | $319.30M | $486.20M | $90.80M | (m) | 2.59× |
| 2017-09-30 | $1.34B | $513.50M | $263.90M | $165.30M | $269.80M | $515.30M | $94.80M | (m) | 2.60× |
| 2017-06-30 | $1.30B | $493.60M | $217.70M | $222.60M | $240.40M | $505.10M | $91.70M | (m) | 2.63× |
| 2017-03-31 | $1.26B | $514.90M | $277.50M | $187.00M | $225.40M | $476.40M | $94.70M | (m) | 2.46× |
| 2016-12-31 | $1.28B | $524.70M | $342.40M | $157.90M | $243.90M | $440.40M | $86.10M | (m) | 2.43× |
| 2016-09-30 | $1.27B | $552.60M | $278.70M | $162.80M | $223.60M | $483.10M | $93.30M | (m) | 2.29× |
| 2016-06-30 | $1.22B | $535.10M | $232.50M | $187.90M | $206.90M | $471.00M | $88.00M | (m) | 2.27× |
| 2016-03-31 | $1.23B | $541.70M | $209.90M | $210.60M | $233.40M | $460.10M | $95.10M | (m) | 2.26× |
| 2015-12-31 | $1.23B | $554.50M | $267.10M | $201.20M | $234.70M | $422.00M | $72.10M | (m) | 2.22× |
| 2015-09-30 | $1.39B | $676.10M | $331.00M | $201.30M | $242.30M | $478.30M | $87.40M | (m) | 2.05× |
| 2015-06-30 | $1.35B | $652.00M | $320.80M | $172.80M | $240.30M | $486.30M | $84.40M | (m) | 2.08× |
| 2015-03-31 | $1.30B | $540.50M | $334.50M | $157.80M | $227.60M | $473.90M | $87.10M | (m) | 2.41× |
| 2014-12-31 | $1.37B | $582.70M | $319.50M | $178.00M | $293.20M | $477.40M | $76.00M | (m) | 2.34× |
| 2014-09-30 | $1.40B | $610.00M | $329.20M | $113.10M | $268.90M | $566.80M | $98.50M | (m) | 2.29× |
| 2014-06-30 | $1.47B | $628.50M | $389.80M | $67.80M | $279.60M | $612.10M | $102.20M | (m) | 2.33× |
| 2014-03-31 | $1.48B | $671.10M | $454.00M | (m) | $295.00M | $620.50M | $116.40M | (m) | 2.20× |
| 2013-12-31 | $1.43B | $648.60M | $438.70M | (m) | $307.60M | $589.80M | $74.80M | (m) | 2.21× |
| 2013-09-30 | $1.37B | $646.80M | $306.80M | (m) | $297.70M | $632.00M | $82.90M | (m) | 2.12× |
| 2013-06-30 | $1.26B | $602.80M | $250.90M | (m) | $300.50M | $601.80M | $69.50M | (m) | 2.10× |
| 2013-03-31 | $1.28B | $643.20M | $269.40M | (m) | $273.40M | $621.70M | $75.80M | (m) | 1.99× |
| 2012-12-31 | $1.31B | $681.80M | $310.60M | (m) | $289.30M | $611.50M | $69.60M | (m) | 1.92× |
| 2012-09-30 | $1.24B | $686.50M | $242.10M | (m) | $264.80M | $632.80M | $78.00M | (m) | 1.81× |
| 2012-06-30 | $1.21B | $751.90M | $240.30M | (m) | $248.80M | $620.30M | $77.40M | (m) | 1.61× |
| 2012-03-31 | $1.25B | $771.50M | $229.50M | (m) | $261.80M | $648.00M | $87.00M | (m) | 1.61× |
| 2011-12-31 | $1.19B | $755.80M | $246.00M | (m) | $282.80M | $576.20M | $72.30M | (m) | 1.58× |
| 2011-09-30 | $1.17B | $919.50M | $195.80M | (m) | $271.10M | $601.40M | $76.50M | (m) | 1.27× |
| 2011-06-30 | $1.17B | $901.70M | $169.80M | (m) | $273.70M | $618.70M | $82.00M | (m) | 1.29× |
| 2011-03-31 | $1.12B | $871.30M | $193.30M | (m) | $250.50M | $571.60M | $81.00M | (m) | 1.28× |
| 2010-12-31 | $1.05B | $831.50M | $230.40M | (m) | $232.90M | $511.00M | $64.00M | (m) | 1.26× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |